A world-first Australian medical therapy that uses stem cells to treat degenerative spinal disease has been approved for testing on patients in the US.
New Jersey’s state Legislature agreed to borrow $270 million (€205 million) to build labs and pay for related programs. Lawmakers decided that this is the right time to invest financially in stem cell research.
EuroStemCell, the European Consortium for Stem Cell Research, most recently have produced promising results for treating the debilitating, often fatal, genetic disorder muscular dystrophy. They published their findings in a recent issue of Nature.